Results 1 - 10 of 231 (Click here to explore results)

<

1

2

3

...

23

24

>

Interaction of N-hydroxyacetamide with vanadate in aqueous solution. Regina T. Yamaki, Eucler B. Paniago, Sandra Carvalho, Oliver W. Howarth, Wynne Kam , J. Chem. Soc., Dalton Trans. , 1997 , 4817

Mechanism and proton activating factors in base-induced β-elimination reactions of 2-(2-chloroethyl)pyridine . Sergio Alunni, Alessandra Busti , J. Chem. Soc., Perkin Trans. 2 , 2001 , 778

Confirmation of the structure of (±)-preisomide by total synthesis. Hong Kang Teo, Patcharaporn Sae-Lao, Roderick W. Bates , Org. Biomol. Chem. , 2023 , 21 , 7954

Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species. Erofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, Vasileios Siozos, Vassilios Myrianthopoulos, Emmanuel Mikros, Martin C. Taylor, John M. Kelly, Niki Vassilaki, Grigoris Zoidis , Med. Chem. Commun. , 2019 , 10 , 991

Amide-imide tautomerism of acetohydroxamic acid in aqueous solution: quantum calculation and SMD simulations. S. Tolosa, N. Mora-Diez, A. Hidalgo, J. A. Sansón , RSC Adv. , 2014 , 4 , 44757

Index of subjects , J. Chem. Soc., Abstr. , 1896 , 70 , B755

Synthesis and structural characterisation of bismuth(iii) hydroxamates and their activity against Helicobacter pylori. Amita Pathak, Victoria L. Blair, Richard L. Ferrero, Peter C. Junk, Richard F. Tabor, Philip C. Andrews , Dalton Trans. , 2015 , 44 , 16903

Half-sandwich type rhodium(iii)–aminohydroxamate complexes: the role of the position of the amino group in metal ion binding. Péter László Parajdi-Losonczi, Péter Buglyó, Hana Skakalova, Jana Kasparkova, Norbert Lihi, Etelka Farkas , New J. Chem. , 2018 , 42 , 7659

Neutral acetohydroxamic acid coordination to a mononuclear Ni(ii) center stabilized by an intramolecular hydrogen-bonding interaction. Katarzyna Rudzka, Magdalena M. Makowska-Grzyska, Ewa Szajna, Atta M. Arif, Lisa M. Berreau , Chem. Commun. , 2005 , 489

Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv. Gayatri Ramakrishnan, Nagasuma R. Chandra, Narayanaswamy Srinivasan , Mol. BioSyst. , 2015 , 11 , 3316